UDP-003, a cyclodextrin-based drug, safely reduces 7-ketocholesterol in Phase 1, potentially reversing atherosclerosis instead of just slowing it. A novel drug that removes toxic cholesterol byproduct...
MIT researchers used mRNA to reprogram dendritic cells, achieving complete tumor regression in over 70% of mice with durable immune memory. A new MIT-led study published in Nature Biotechnology demons...
The 2026 Alzheimer’s clinical trials pipeline shows a strategic shift from amyloid to inflammation and tau targets, with combination therapies and repurposed drugs leading the way. In 2026, the Alzh...
New study shows lifestyle factors have three times greater impact on survival past 80 than genetic predisposition. A landmark study reveals that healthy habits outweigh genes for living longer, even i...
Alzheimer’s Drug Development Revolution: Inflammation and Tau Take Center Stage as Amyloid Era Fades
The 2024 pipeline report reveals a dramatic shift from amyloid to inflammation and tau targets, with repurposed drugs and combination therapies leading a new era of Alzheimer’s treatment. New re...
New research shows modifiable lifestyle factors add up to 7 years of life expectancy in older adults, even those with high genetic risk. A landmark study reveals that diet, exercise, and not smoking c...
A March 2025 study in Cell Reports Medicine finds that muscle loss from GLP-1 drugs mirrors ordinary weight loss, alleviating public concern. A new study reassures that GLP-1 drugs do not cause dispro...
AI4L 1.0 uses audit-driven prompting to produce hallucination-free, citation-verified longevity reviews, addressing widespread distrust in AI health advice. Forever Healthy’s AI4L 1.0 promises to re...
New research links inflammaging and immunosenescence to Alzheimer’s and Parkinson’s, with immune-modulating therapies showing early promise. Aging of the immune system accelerates brain di...
Explore how partial reprogramming using Yamanaka factors reverses epigenetic aging, with recent advances in mice and early clinical trials paving the way for rejuvenation therapies. Partial reprogramm...
